Biomarkers for risk assessment in molecular epidemiology of cancer.
about
Plasma haptoglobin and immunoglobulins as diagnostic indicators of deoxynivalenol intoxicationPancreatic cancer epidemiology.Cancer biomarkers: are we ready for the prime time?Pancreatic cancer biomarkers and their implication in cancer diagnosis and epidemiology.Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis.
P2860
Biomarkers for risk assessment in molecular epidemiology of cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biomarkers for risk assessment in molecular epidemiology of cancer.
@ast
Biomarkers for risk assessment in molecular epidemiology of cancer.
@en
type
label
Biomarkers for risk assessment in molecular epidemiology of cancer.
@ast
Biomarkers for risk assessment in molecular epidemiology of cancer.
@en
prefLabel
Biomarkers for risk assessment in molecular epidemiology of cancer.
@ast
Biomarkers for risk assessment in molecular epidemiology of cancer.
@en
P2860
P1476
Biomarkers for risk assessment in molecular epidemiology of cancer.
@en
P2093
P2860
P304
P356
10.1177/153303460400300512
P577
2004-10-01T00:00:00Z